Previous studies (Li et al., 2022; Zhang et al., 2023a; Shangguan et al., 2024) suggest that CISD2 may play a role in promoting tumor cell proliferation and drug resistance through ferroptosis and ferritinophagy (Li et al., 2022). The gene discussed is CISD2; the disease is neoplasm.